A streamlined workflow for early phase formulation development of monoclonal antibodies comprising multi-attribute method and ligand binding assay | Synapse
March 3, 2026
A streamlined workflow for early phase formulation development of monoclonal antibodies comprising multi-attribute method and ligand binding assay
Key Points
Early phase formulation development of monoclonal antibodies benefits from a streamlined workflow, enhancing efficiency.
The proposed approach integrates a multi-attribute method with ligand binding assays, simplifying processes.
Observational analysis across various parameters reveals the potential for reduced development times.
Enhancements in the formulation process may lead to quicker availability of biopharmaceuticals to the market.